Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03494556 · ClinicalTrials.gov registry record
Prehospital Translation of Chest Pain Tools
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 365
- Enrollment target
NCT03494556: Completed study, sponsored by Wake Forest University Health Sciences.
NCT03494556 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 365 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03494556 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 365 participants
- Enrollment target
Study Summary
Decision aids such as the HEART Pathway, Emergency Department Assessment of Chest Pain Score (EDACS), Revised Geneva Score and PERC Score have similar ability to accurately risk stratify Emergency Department (ED) patients with possible Acute Coronary Syndrome (ACS) and Pulmonary Embolism (PE) and have become standard practice in the ED setting. This study seeks to determine whether prehospital use of these decision aids is feasible and determine which are the most sensitive and specific for prediction of ACS and PE, respectively.
Primary Outcome
Paramedics and blinded Emergency Department providers will be complete four risk stratification tools on a convenience sample of patients with acute chest pain. Inter-rater reliability (kappa) will be determined for each tool.
Interventions
- OTHER Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2020-09-09 |
What the finished NCT03494556 record still lists
NCT03494556 is an observational study that tracks outcomes without assigning an intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Data Collection is the first listed.
NCT03494556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03494556 about?
NCT03494556 is a clinical study titled "Prehospital Translation of Chest Pain Tools". Decision aids such as the HEART Pathway, Emergency Department Assessment of Chest Pain Score (EDACS), Revised Geneva Score and PERC Score have similar ability to accurately risk stratify Emergency Department (ED) patients with possible Acute Coronary Syndrome (ACS) and Pulmonary Embolism (PE) and ha...
What is the current status of trial NCT03494556?
This trial is currently completed. The enrollment target is 365 participants. The study started on 2018-04-18. Estimated completion is 2020-09-09.
What interventions are being tested in trial NCT03494556?
The interventions under investigation include: Data Collection (OTHER).
Who is sponsoring clinical trial NCT03494556?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI